Amyloid blood biomarker detects Alzheimer's disease-Reference-Cited by-同舟云学术

Amyloid blood biomarker detects Alzheimer's disease

Published:2018-04-06 Issue:5 Volume:10 Page:
ISSN:1757-4676
Container-title:EMBO Molecular Medicine
language:en
Short-container-title:EMBO Mol Med

Author:

Nabers Andreas¹,Perna Laura²,Lange Julia¹,Mons Ute²,Schartner Jonas¹,Güldenhaupt Jörn¹,Saum Kai‐Uwe²,Janelidze Shorena³,Holleczek Bernd⁴,Rujescu Dan⁵,Hansson Oskar³⁶^ORCID,Gerwert Klaus¹^ORCID,Brenner Hermann²⁷

Affiliation:

1. Department of Biophysics Ruhr‐University Bochum Bochum Germany

2. Division of Clinical Epidemiology and Aging Research German Cancer Research Center (DKFZ) Heidelberg Germany

3. Department of Clinical Sciences Lund University Lund Sweden

4. Saarland Cancer Registry Saarbrücken Germany

5. Department of Psychiatry, Psychotherapy and Psychosomatics University of Halle Halle Germany

6. Memory Clinic Skåne University Hospital Malmö Sweden

7. Network Aging Research (NAR) University of Heidelberg Heidelberg Germany

Funder

Universität Heidelberg

Ministerium für Wissenschaft, Forschung und Kunst Baden-Württemberg

Hjärnfonden

Roche

GE Healthcare

Biogen

Fujirebio Europe

Eli Lilly and Company

Publisher

EMBO

Subject

Molecular Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.15252/emmm.201708763

Reference38 articles.

1. Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease

2. Alzheimer's disease

3. Cerebrospinal fluid and plasma biomarkers in Alzheimer disease

4. Amyloid biomarkers in Alzheimer's disease

Cited by 154 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Alpha-synuclein misfolding as a fluid biomarker for Parkinson’s disease and synucleinopathies measured with the iRS platform;2024-09-04

2. Risk factors for cognitive decline in non-demented elders with amyloid-beta positivity;Alzheimer's Research & Therapy;2024-08-19

3. Novel β-amyloid PET Imaging Study of [¹⁸F]92 in Patients with Cognitive Decline;ACS Omega;2024-08-01

4. Alzheimer’s disease: from early pathogenesis to novel therapeutic approaches;Metabolic Brain Disease;2024-07-24

5. Atomic force microscopy in the characterization and clinical evaluation of neurological disorders: current and emerging technologies;Med-X;2024-06-03